A large-scale study published in Molecular Psychiatry has uncovered a distinct pattern of biological changes in people with ...

Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...

J&J is discontinuing the Phase 3 test of its drug, aticaprant, in major depressive disorder “due to insufficient efficacy in the target patient population,” the company said after Thursday’s ...

Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and ...

Charlie Health provides information on data highlighting the link between romantic relationships and mental health—plus some ...

In a statement released Thursday afternoon, J&J said it will stop developing the drug, called aticaprant, as an add-on ...

Major depressive disorder with seasonal patterns, also known as seasonal affective disorder, causes symptoms similar to ...

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good thing? And is depression weight loss even a thing in the first place?

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...